Karen Carter

Ms. Carter is one of the regulatory specialists for the Center. She works with study coordinators and principal investigators to ensure accuracy, patient safety, and consistency with the standards and requirements of the IRB, the Cancer Protocol Committee (CPC) as well as the Food and Drug Administration (FDA). Her projects include new study submissions, protocol amendments, safety reporting and renewals.